ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024

Stock Information for ProPhase Labs Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ProPhase Labs Inc.

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event
ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024
ProPhase Labs Announces Collaboration with Forward Healthcare Consultants to Aid in the Commercialization of its Billion Dollar Potential BE-Smart Esophageal Cancer Test
PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14
ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.